Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...
May 4, 2010 (Barcelona, Spain) — Monthly infusions of the bisphosphonate zoledronic acid significantly reduce the risk for bone fractures in men with prostate cancer and malignant bone metastases, ...
Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...
TTUHSC researcher Srinivas Nandana, Ph.D., (left) and co-investigator Manisha Tripathi, Ph.D., received a grant from the U.S. Department of Defense to investigate the role of TBX2 in establishing the ...
F Saad has received speaker honoraria and financial compensation for participating in advisory boards for Amgen Janssen and Novartis Corporation. K Pantel has received research grant and speaker ...
Results suggest bone-protecting agents should be used in patients with metastatic castration-resistant prostate cancer and bone metastasis, especially in the era of androgen receptor pathway ...
When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...
PSMA-delay castration (DC): An open-label, multicenter, randomized phase 3 study of [177Lu]Lu-PSMA-617 versus observation in patients with metachronous PSMA-positive oligometastatic prostate cancer ...
State House subcommittee to hold public hearing on two controversial abortion bills The South Carolina House Judiciary Constitutional Laws Subcommittee is set to hear testimony on two controversial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback